Heilsa Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 24.00 Cr
- Paid Up Capital ₹ 14.50 Cr
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 211.25 Cr
- Satisfied Charges ₹ 147.00 Cr
- Revenue Growth %
- Profit Growth 919.66%
- Ebitda -100.23%
- Net Worth 1410.85%
- Total Assets 138.42%
About Heilsa Life Sciences
Heilsa Life Sciences Private Limited (HLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 September 2021 (Three years and four months 26 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 24.00 Cr and a paid-up capital of Rs 14.50 Cr.
The company currently has active open charges totaling ₹211.25 Cr. The company has closed loans amounting to ₹147.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Puneet Kansal, Sumit Agarwal, Ruchir Gupta, and Two other members serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100DL2021PTC387167
- Company No.
387167
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Heilsa Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ruchir Gupta  | Managing Director | 26-Sep-2021 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Puneet Kansal | Whole-Time Director | 26-Sep-2021 | Current |
| Sumit Agarwal | Director | 26-Sep-2021 | Current |
| Vijaysing Bhandari | Director | 16-Mar-2022 | Current |
| Yasha Agarwal | Director | 25-Jan-2023 | Current |
Financial Performance of Heilsa Life Sciences.
Heilsa Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 919.66% increase in profit. The company's net worth Soared by an impressive increase of 1410.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Heilsa Life Sciences?
Unlock access to Heilsa Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Phd Chamber Of Commerce And IndustrySumit Agarwal is a mutual person
Vaishno Fertilizer Private LimitedPuneet Kansal is a mutual person
- Axa Parenterals Limited
Puneet Kansal, Sumit Agarwal and 3 more are mutual person
- Goldenyellow Paper Llp
Sumit Agarwal is a mutual person
- Omanand Papers Private Limited
Sumit Agarwal is a mutual person
- Humanix Lifesciences Private Limited
Sumit Agarwal and Ruchir Gupta are mutual person
Charges (Loans)
₹211.25 Cr
₹147.00 Cr
Charges Breakdown by Lending Institutions
- Others : 211.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2023 | Others | ₹147.00 Cr | Open |
| 11 Mar 2022 | Others | ₹64.25 Cr | Open |
| 11 Mar 2022 | Others | ₹147.00 Cr | Satisfied |
How Many Employees Work at Heilsa Life Sciences?
Unlock and access historical data on people associated with Heilsa Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Heilsa Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heilsa Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
